About the Authors
Adam Bisaga, MD, is an addiction psychiatrist, clinician, researcher, and professor of psychiatry at Columbia University. He conducts research on new treatments for opioid addiction and oversees a national program that mentors physicians treating opioid addictions. He is a UN expert involved in international addiction training and program development, and he recently co-edited the UN/WHO International Standards for the Treatment of Drug Use Disorders.
Karen Chernyaev is a writer and editor with more than thirty years experience in publishing. She has worked on dozens of books on addic-tion treatment, recovery, and related topics.
Index
A
abstinence-based programs
addiction
addiction treatment
See also opioid addiction treatment
addiction treatment centers
adolescents
B
brain chemistry
See also opioid receptor system
buprenorphine
See also road through addiction to recovery (Erics story)
C
community reinforcement and family
. See also triggers and trigger avoidance
D
detoxification
See also withdrawal
doctors. See medical professionals
E
Erics story. See road through addiction to recovery (Erics story)
F
facilities. See addiction treatment centers
families
fentanyl
G
H
I
J
K
L
M
MAT. See medication-assisted treatment
medical professionals
medication-assisted treatment (MAT)
See also OUD treatment/overdose prevention medications
mental illness
methadone
. See also opioid receptor system
N
naloxone
naltrexone
See also XR-naltrexone
Narcan. See naloxone
O
opiates
opioids
See also cycles of opioid use in America; fentanyl; methadone; opiates
opioid addiction. See opioid use disorder
See also medication-assisted treatment; OUD treatment/overdose prevention medications
. See also social context of addiction crisis
See also recovery
opioid receptor system
See also medication-assisted treatment; OUD treatment/overdose prevention medications; entries beginning with OUD
See also adolescents
, 100, 199
See also buprenorphine; methadone; naltrexone
. See also naloxone
overdose epidemic
See also naloxone; tolerance to opioids
P
. See also chronic pain
personality disorder approach, xxi
psychiatric disorders. See mental illness
R
See also opioid-free by choice
relapse
road through addiction to recovery (Erics story)
S
social context of addiction crisis
overview, x
support groups
T
teenagers. See adolescents
tolerance to opioids
U
United States
V
W
withdrawal
See also detoxification; opioid-free by choice
X
XR-naltrexone
See also naltrexone
Y
NOTES
: Jane Porter and Hershel Jick, Addiction Rare in Patients Treated with Narcotics, New England Journal of Medicine 302, no. 2 (January 1980): 123, ncbi.nlm.nih.gov/pubmed/7350425.
.
.
.
: Center for Behavioral Health Statistics and Quality, Results from the 2014.
.
.
.
.
.
.
: Hedegaard, Drug Overdose Deaths.
: Hedegaard, Drug Overdose Deaths.
.
.
.
: Hedegaard, Drug Overdose Deaths
.
.
.
: Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS): 2013. Data on Substance Abuse Treatment Facilities, Substance Abuse and Mental Health Services Administration, 2014.
.
: David T. Courtwright, Dark Paradise: A History of Opiate Addiction in America (Cambridge: Harvard University Press, 1982; President and Fellows of Harvard College, 2001), loc. 1230 of 4538, Kindle.
.
: Richard P. Mattick et al., Buprenorphine Maintenance Versus Placebo or Methadone Maintenance for Opioid Dependence, Cochrane Database of Systematic Reviews (February 2014), doi.org/10.1002/14651858.CD002207.pub4; J. F. Maddux and D. P. Desmond, Methadone Maintenance and Recovery from Opioid Dependence, American Journal of Drug and Alcohol Abuse 18, no. 1 (1992): 6374.
.
.
: Kerr, Growth in Heroin Use.
.
.
.
: Center for Behavioral Health Statistics and Quality, Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health, 2016, samhsa.gov/data/; Substance Abuse and Mental Health Services Administration, National Survey
.
.
.
.
.
.
: Adapted from American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (5th ed.) (Arlington, VA: American Psychiatric Publishing, 2013).
.
.
.
.
.
; Yih-Ing Hser, Treatment Retention among Patients; Richard P. Mattick, Buprenorphine Maintenance versus Placebo.
.
: Joshua D. Lee, Comparative Effectiveness of.
: Erin Kelty and G. Hulse, A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral
.
.
.
.
: William R. Miller and Stephen Rollnick, Motivational Interviewing: Helping People Change, 3rd ed. (New York: Guilford Press, 2012).
.
: Robert J. Meyers and Brenda L. Wolfe, Get Your Loved One Sober: Alternatives to Nagging, Pleading, and Threatening (Center City, MN: Hazelden, 2003).
.
: Adam R. Winstock et al., Should I stay or should I go? Coming off methadone and buprenorphine treatment, International Journal of Drug Policy 22, no. 1 (2011): 7781.
.
.
.
ADVANCE PRAISE FOR
overcoming opioid addiction
A desperately needed, science-based solution to the nations worst-ever drug crisis.
Herbert D. Kleber, MD , founder of the Drug Dependence Unit, Yale University, and Division of Substance Abuse, Columbia University
A must-read. Compassionate, readable, and scientifically sound, this is the first book Ive seen that covers opioid addiction comprehensively and accurately. Dr. Bisaga masterfully reviews what caused the epidemic, the latest research on how to treat opioid use disorders, and how families and loved ones can effectively support those who are suffering. In the chaotic confusion in the media and elsewhere about how to solve this crisis, Overcoming Opioid Addiction presents both a clear path forward and the evidence to support it.
Omar Manejwala, MD , Chief Medical Officer, Catasys, and author of Craving: Why We Cant Seem to Get Enough
Overcoming Opioid Addiction is an accessible, practical, comprehensive guide for health care providers, patients, and families. A great go-to source of information on all things opioidsIm recommending it to my patients!
Anna Lembke, MD , Chief of Addiction Medicine at Stanford University School of Medicine and author of Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why Its So Hard to Stop